Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Incubator/Accelerator | Alive

About FirstKind

FirstKind makes a product called Geko that aids with blood circulation.

FirstKind Headquarters Location

High Wycombe, England,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing FirstKind

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

FirstKind is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,575 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Latest FirstKind News

Sky Medical Technology announces availability of its geko™ device on government of India e-marketplace portal (GeM)

Apr 7, 2022

Text Size: A+ Daresbury [England], April 7 (ANI/PRNewswire): Sky Medical Technology Ltd (Sky), a UK-based medical device manufacturer and parent company of Firstkind Ltd, today announced the availability of its flagship product, the geko™ device, on the Government of India e-Marketplace (GeM) procurement portal, under the Product ID 8778588-83575686384, Gem Catalogue ID 5116877-12688567087 Launched in August 2016, the GeM portal is an online market platform to facilitate procurement of goods and services by various Ministries and agencies of the Government. It aims to enhance transparency, efficiency, and speed in the public procurement of goods and services. The wearable, clinically proven geko™ device – now listed on GeM – is a small, battery powered, disposable, neuromuscular electro-stimulation therapy, that is applied non-invasively to the skin over the common peroneal nerve at the side of the knee. Small electrical pulses gently stimulate the nerve, once every second, activating the calf and foot muscle pumps resulting in increased blood flow in the deep veins1 of the calf, at rate equal to 60% of continuous walking2 without a patient having to move. The increase in blood flow prevents venous thromboembolism3 (VTE – blood clots), reduces post-operative and trauma-based swelling4,5 and promotes wound healing (leg ulcers)6. Across India, the incidence of VTE is comparable to that in Western countries. The risk is especially high in hospitalized patients, in a majority of whom VTE is clinically silent and one of the commonest causes of unplanned readmission and preventable death7. Oedema, the medical term for swelling, is also a silent burden with few tools to address the complication, which can delay surgical fixation, impede wound closure, decrease muscle strength and stall rehabilitation.8,9 Arguably the greatest burden, however, and considered a silent epidemic, is chronic wounds. It is difficult to correctly assess the magnitude of suffering generated by leg ulcers in a country of over 1.2 billion people. One study, however, estimated the prevalence to be 4.5 per 1000 in the population10. “We are thrilled that government hospitals across India can now enjoy streamlined geko™ device procurement through GeM, to address these significant medical challenges” says Bernard Ross, Sky Founder and CEO. “GeM listing marks the beginning of a very-exciting journey for Sky. The online platform is a vibrant e-marketplace, providing transparency, efficiency and speed. It is heartening to know that thousands of patients who visit government hospitals can now gain from the prescribed use of the geko™ device for better clinical outcomes and enhanced recovery. Sky Medical Technology, the parent of Firstkind Ltd, is a UK-based medical devices company. Through its innovative mechanism of neuromuscular electrostimulation, Sky has developed a non-invasive, ground-breaking technology platform, OnPulse™, embedded in its industry-leading brand, the geko™ device. Sky’s products are tailored to different medical application areas, selling through strategic partnerships or distributors in each clinical application area. Clinical areas of focus include prevention of life-threatening blood clots, complications related to swelling before and after general and orthopaedic surgery and vascular conditions related to wound healing (leg ulcers). The goal in each pathway is to partner with healthcare professionals for better patient outcomes and patient care whilst saving health system resources. This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire) This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content. Subscribe to our channels on YouTube & Telegram Why news media is in crisis & How you can fix it India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises. But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle. ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here .

FirstKind Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

FirstKind Rank

  • Where is FirstKind's headquarters?

    FirstKind's headquarters is located at High Wycombe.

  • What is FirstKind's latest funding round?

    FirstKind's latest funding round is Incubator/Accelerator.

  • Who are the investors of FirstKind?

    Investors of FirstKind include TMCx.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.